Đang chuẩn bị liên kết để tải về tài liệu:
Predictors of recurrence free survival for patients with stage II and III colon cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The aim of this study was to evaluate clinico-pathologic specific predictors of recurrence for stage II/III disease. Improving recurrence prediction for resected stage II/III colon cancer patients could alter surveillance strategies, providing opportunities for more informed use of chemotherapy for high risk individuals. |

TÀI LIỆU LIÊN QUAN

Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: A multiinstitutional study of 61 subjects

Báo cáo khoa học: " Buccal mucosa carcinoma: surgical margin less than 3 mm, not 5 mm, predicts locoregional recurrence"

PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma

Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma

The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer